UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

GOG 244 - The Lymphedema and Gynecologic cancer (LeG) study: The impact of lower-extremity lymphedema on quality of life, psychological adjustment, physical disability, and function

Gynecologic oncology, 2021-01, Vol.160 (1), p.244-251

2021

Volltextzugriff (PDF)

Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology–Gynecologic Oncology Group protocol 240)

The lancet oncology, 2015-03, Vol.16 (3), p.301-311

2015

Volltextzugriff (PDF)

Health-Related Quality of Life During and After Intraperitoneal Versus Intravenous Chemotherapy for Optimally Debulked Ovarian Cancer: A Gynecologic Oncology Group Study

Journal of clinical oncology, 2007-02, Vol.25 (4), p.437-443

2007

Volltextzugriff (PDF)

Attitudes of physicians and patients toward immediate and intraoperative chemotherapy treatment in colon cancer

Cancer treatment and research communications, 2024-01, Vol.39, p.100798, Article 100798

2024

Volltextzugriff (PDF)

The association between quality of life domains and overall survival in ovarian cancer patients during adjuvant chemotherapy: A Gynecologic Oncology Group Study

Gynecologic oncology, 2012-03, Vol.124 (3), p.379-382

2012

Volltextzugriff (PDF)

Stress, Immunity, and Cervical Cancer: Biobehavioral Outcomes of a Randomized Clinical Trail

Clinical cancer research, 2008-04, Vol.14 (7), p.2111-2118

2008

Volltextzugriff (PDF)

Randomized, Controlled Trial of an Easy-to-Read Informed Consent Statement for Clinical Trial Participation: A Study of the Eastern Cooperative Oncology Group

Journal of clinical oncology, 2003-03, Vol.21 (5), p.836-842

2003

Volltextzugriff (PDF)

Resilience, reflection, and residual stress in ovarian cancer survivorship: A gynecologic oncology group study

Psycho-oncology (Chichester, England), 2002-03, Vol.11 (2), p.142-153

2002

Volltextzugriff (PDF)

Effects of the WRITE Symptoms Interventions on Symptoms and Quality of Life Among Patients With Recurrent Ovarian Cancers: An NRG Oncology/GOG Study (GOG-0259)

Journal of clinical oncology, 2022-05, Vol.40 (13), p.1464-1473

2022

Volltextzugriff (PDF)

Patient reported outcomes for cisplatin and radiation followed by carboplatin/paclitaxel versus carboplatin/paclitaxel for locally advanced endometrial carcinoma: An NRG oncology study

Gynecologic oncology, 2022-02, Vol.164 (2), p.428-436

2022

Volltextzugriff (PDF)

Disparities in health-related quality of life in women undergoing treatment for advanced ovarian cancer: the role of individual-level and contextual social determinants

Supportive care in cancer, 2019-02, Vol.27 (2), p.531-538

2019

Volltextzugriff (PDF)

Prospective follow-up of quality of life for participants undergoing risk-reducing salpingo-oophorectomy or ovarian cancer screening in GOG-0199: An NRG Oncology/GOG study

Gynecologic oncology, 2020-01, Vol.156 (1), p.131-139

2020

Volltextzugriff (PDF)

Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group study

International journal of gynecological cancer, 2020-05, Vol.30 (5), p.596-601

2020

Volltextzugriff (PDF)

Neurotoxicity in ovarian cancer patients on Gynecologic Oncology Group (GOG) protocol 218: Characteristics associated with toxicity and the effect of substitution with docetaxel: An NRG Oncology/Gynecologic Oncology Group study

Gynecologic oncology, 2015-02, Vol.136 (2), p.323-327

2015

Volltextzugriff (PDF)

Longitudinal change in telomere length and the chronic stress response in a randomized pilot biobehavioral clinical study: implications for cancer prevention

Cancer prevention research (Philadelphia, Pa.), 2012-10, Vol.5 (10), p.1173-1182

2012

Volltextzugriff (PDF)

Quality of Life Considerations in Gynecologic Cancer

International journal of gynecology and obstetrics, 2006-11, Vol.95 (S1), p.S247-S257

2006

Volltextzugriff (PDF)

Age‐related differences in the quality of life of breast carcinoma patients after treatment

Cancer, 1999-11, Vol.86 (9), p.1768-1774

1999

Volltextzugriff (PDF)

Clinical trial endpoints in ovarian cancer: Report of an FDA/ASCO/AACR Public Workshop

Gynecologic oncology, 2007-11, Vol.107 (2), p.173-176

2007

Volltextzugriff (PDF)

Survivorship as an Element of Clinical Trials in Ovarian Cancer

International journal of gynecological cancer, 2011-05, Vol.21 (4), p.788-792

2011

Volltextzugriff (PDF)

Quality-of-life results used to endorse changes in standard of care for recurrent platinum-sensitive ovarian cancer

Expert review of pharmacoeconomics & outcomes research, 2012-06, Vol.12 (3), p.279-281

2012

Volltextzugriff (PDF)

Cervical Cancer: Behavioral factors related to screening, diagnosis, and survivors' quality of life

Cancer, 2003-11, Vol.98 (9), p.2009-2014

2003

Volltextzugriff (PDF)

Attitudes of physicians and patients toward the timing of adjuvant treatment in colon cancer

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e15596-e15596

2022

Volltextzugriff (PDF)

Supportive care for women with gynecologic cancers

Expert review of anticancer therapy, 2008-02, Vol.8 (2), p.227-241

2008

Volltextzugriff (PDF)

1 – 25 von 78

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(63)

Publikationsform

Sprache

Englisch
(78)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

GOG 244 - The Lymphedema and Gynecologic cancer (LeG) study: The impact of lower-extremity lymphedema on quality of life, psychological adjustment, physical disability, and function

Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology–Gynecologic Oncology Group protocol 240)

Health-Related Quality of Life During and After Intraperitoneal Versus Intravenous Chemotherapy for Optimally Debulked Ovarian Cancer: A Gynecologic Oncology Group Study

Attitudes of physicians and patients toward immediate and intraoperative chemotherapy treatment in colon cancer

The association between quality of life domains and overall survival in ovarian cancer patients during adjuvant chemotherapy: A Gynecologic Oncology Group Study

Health-related quality of life and patient-centred outcomes with olaparib maintenance after chemotherapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT Ov-21): a placebo-controlled, phase 3 randomised trial

Stress, Immunity, and Cervical Cancer: Biobehavioral Outcomes of a Randomized Clinical Trail

Randomized, Controlled Trial of an Easy-to-Read Informed Consent Statement for Clinical Trial Participation: A Study of the Eastern Cooperative Oncology Group

Resilience, reflection, and residual stress in ovarian cancer survivorship: A gynecologic oncology group study

Cediranib and Olaparib Combination Compared With Cediranib or Olaparib Alone, or Chemotherapy in Platinum-Resistant or Primary Platinum-Refractory Ovarian Cancer: NRG-GY005

Effects of the WRITE Symptoms Interventions on Symptoms and Quality of Life Among Patients With Recurrent Ovarian Cancers: An NRG Oncology/GOG Study (GOG-0259)

Patient reported outcomes for cisplatin and radiation followed by carboplatin/paclitaxel versus carboplatin/paclitaxel for locally advanced endometrial carcinoma: An NRG oncology study

Disparities in health-related quality of life in women undergoing treatment for advanced ovarian cancer: the role of individual-level and contextual social determinants

Prospective follow-up of quality of life for participants undergoing risk-reducing salpingo-oophorectomy or ovarian cancer screening in GOG-0199: An NRG Oncology/GOG study

Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group study

Neurotoxicity in ovarian cancer patients on Gynecologic Oncology Group (GOG) protocol 218: Characteristics associated with toxicity and the effect of substitution with docetaxel: An NRG Oncology/Gynecologic Oncology Group study

Longitudinal change in telomere length and the chronic stress response in a randomized pilot biobehavioral clinical study: implications for cancer prevention

Quality of Life Considerations in Gynecologic Cancer

Age‐related differences in the quality of life of breast carcinoma patients after treatment

Clinical trial endpoints in ovarian cancer: Report of an FDA/ASCO/AACR Public Workshop

Survivorship as an Element of Clinical Trials in Ovarian Cancer

Quality-of-life results used to endorse changes in standard of care for recurrent platinum-sensitive ovarian cancer

Cervical Cancer: Behavioral factors related to screening, diagnosis, and survivors' quality of life

Attitudes of physicians and patients toward the timing of adjuvant treatment in colon cancer

Supportive care for women with gynecologic cancers

Suchergebnisse filtern